Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma

Hepatology. 2021 Jul;74(1):483-490. doi: 10.1002/hep.31697. Epub 2021 Jun 28.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / therapy*
  • Chemotherapy, Adjuvant / methods
  • Chemotherapy, Adjuvant / trends
  • Disease-Free Survival
  • Hepatectomy
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Liver Neoplasms / mortality
  • Liver Neoplasms / therapy*
  • Neoadjuvant Therapy / methods
  • Neoadjuvant Therapy / trends*
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasm Recurrence, Local / prevention & control
  • Progression-Free Survival
  • Protein Kinase Inhibitors / therapeutic use
  • Randomized Controlled Trials as Topic

Substances

  • Antineoplastic Agents, Immunological
  • Immune Checkpoint Inhibitors
  • Protein Kinase Inhibitors